Epicardial adipose tissue: More than a simple fat deposit?;Tejido adiposo epicárdico: ¿más que un simple depósito de grasa?

Endocrinologia y Nutricion

Volumn 60, Issue 6, 2013, Pages 320-328

  Lima Martínez, Marcos M ^a,b   Blandenier, Claudia ^c   Iacobellis, Gianluca ^d  

^a Hospital Universitario de Los Andes   (Venezuela)

^b Universidad de Oriente Nucleo Bolivar   (Venezuela)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Epicardial adipose tissue; Epicardial fat; Metabolic syndrome; Obesity

Indexed keywords

ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; CARDIOMETABOLIC RISK; CORONARY ARTERY DISEASE; DRUG TARGETING; EPICARDIUM; HEART LEFT VENTRICLE MASS; HUMAN; METABOLIC SYNDROME X; OBESITY; SHORT SURVEY;

ADIPOSE TISSUE; CORONARY ARTERY DISEASE; HUMANS; PERICARDIUM;

EID: 84879607483     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2012.08.001     Document Type: Short Survey

References (100)

1. Yusuf S., Hawken S., Ounpuu S., Bautista L., Franzosi M.G., Commerford P., et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005, 366:1640-1649.
2. Rimm E.B., Stampfer M.J., Giovannucci E., Ascherio A., Spiegelman D., Colditz G.A., et al. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 1995, 141:1117-1127.
3. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116:337-350.
4. Bays H.E. "Sick fat", metabolic disease, and atherosclerosis. Am J Med 2009, 122:S26-S37.
5. Lima-Martínez M.M., Iacobellis G. Grasa epicárdica: una nueva herramienta para la evaluación del riesgo cardiometabólico. Hipertens riesgo vasc 2011, 28:63-68.
6. Reiner L., Mazzoneli A., Rodríguez F.L. Statistical analysis of the epicardial fat weight in human hearts. AMA Arch Pathol 1955, 60:369-373.
7. Iacobellis G., Corradi D., Sharma A.M. Epicardial adipose tissue: anatomical, biomolecular and clinical relation to the heart. Nat Cardiovasc Clin Pract Med 2005, 2:536-543.
8. Sacks H.S., Fain J.N. Human epicardial adipose tissue: a review. Am Heart J 2007, 153:907-917.
9. Company J.M., Booth F.W., Laughlin M.H., Arce-Esquivel A.A., Sacks H.S., Bahouth S.W., et al. Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat. J Appl Physiol 2010, 109:1904-1912.
10. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
11. Bambace C., Telesca M., Zoico E., Sepe A., Olioso D., Rossi A., et al. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011, 20:e153-e156.
12. Eiras S., Teijeira-Fernández E., Salgado-Somoza A., Couso E., García-Caballero T., Sierra J., et al. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 2010, 51:207-212.
13. Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring) 2009, 17:625.
14. Lima M.M. Grasa epicárdica: un nuevo indicador de riesgo cardiometabólico. Avances Cardiol 2010, 30:331-337.
15. Marchington J.M., Pond C.M. Site specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high - fat feeding on lipogenesis and the incorporation of fatty acids in vivo. Int J Obesity 1990, 14:1013-1022.
16. Vural B., Atalar F., Ciftci C., Demirkan A., Susleyici-Duman B., Gunay D., et al. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovasc Pathol 2008, 17:392-398.
17. Malavazos A.E., di Leo G., Secchi F., Lupo E.N., Dogliotti G., Coman C., et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010, 105:1831-1835.
18. Kankaanpaa M., Lehto H.R., Parkka J.P., Komu M., Viljanen A., Ferrannini E., et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006, 91:4689-4695.
19. Ritchie R.H. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance. Heart Lung Circ 2009, 18:11-18.
20. Chiu H.C., Kovacs A., Ford D.A., Hsu F.F., Garcia R., Herrero P., et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001, 107:813-822.
21. Iacobellis G., Malavazos A.E., Corsi M.M. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol 2011, 43:1651-1654.
22. Saely C.H., Geiger K., Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology 2012, 58:15-23.
23. Mattson M.P. Perspective: Does brown fat protect against diseases of aging?. Ageing Res Rev 2010, 9:69-76.
24. Richard D., Picard F. Brown fat biology and thermogenesis. Front Biosci 2011, 16:1233-1260.
25. Sacks H.S., Fain J.N., Holman B., Cheema P., Chary A., Parks F., et al. Uncoupling protein-1 and related mRNAs in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab 2009, 94:3611-3615.
26. Marchington J.M., Mattacks C.A., Pond C.M. Adipose tissue in the mammalian heart and pericardium; structure, foetal development and biochemical properties. Comp Biochem Physiol 1989, 94:225-232.
27. Iacobellis G., Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 2008, 40:442-445.
28. Baker A.R., Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1.
29. Iacobellis G., Bianco A.C. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 2011, 22:450-457.
30. Prescott M.F., McBride C.K., Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol 1989, 135:835-846.
31. Shimokawa H., Ito A., Fukumoto Y., Kadokami T., Nakaike R., Sakata M., et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo, the role of platelet-derived growth factor. J Clin Invest 1996, 97:769-776.
32. Miyata K., Shimokawa H., Kandabashi T., Higo T., Morishige K., Eto Y., et al. Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol 2000, 20:2351-2358.
33. Lima M.M., Rosa F.J., Marin A., Romero-Vecchione E. Adiponectina y sus efectos pleiotrópicos en el sistema cardiovascular. Rev Venez Endocrinol Metab 2009, 7:3-9.
34. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R., Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
35. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
36. Schulze M.B., Shai I., Rimm E.B., Li T., Rifai N., Hu F.B. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005, 54:534-539.
37. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
38. Lima M.M., Torres C., Rosa F., Romero-Vecchione E., Guerra E., Zerpa J. Adrenomedulina: ¿más que una simple hormona?. Rev Venez Endocrinol Metab 2011, 9:4-11.
39. Shinomiya K., Ohmori K., Ohyama H., Hosomi N., Takahashi T., Osaka K. Association of plasma adrenomedullin with carotid atherosclerosis in chronic ischemic stroke. Peptides 2001, 22:1873-1880.
40. Savoia C., Schiffrin E.L. Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin. Med Clin N Am 2004, 88:39-62.
41. Jougasaki M., Grantham J.A., Redfield R.R., Burnett J.C. Regulation of cardiac adrenomedullin in heart failure. Peptides 2001, 22:1841-1850.
42. Hayashi M., Shimosawa T., Isaka M., Yamada S., Fujita R., Fujita T. Plasma adrenomedullin in diabetes. Lancet 1997, 350:1449-1450.
43. Cases A., Esforzado N., Vera M., Lario S., López-Pedret J., Jiménez W., et al. Niveles elevados de adrenomedulina en pacientes hipertensos en programa de hemodiálisis. Nefrologia 2000, 20:424-430.
44. Torres C., Lima-Martínez M.M., Rosa F.J., Guerra E., Paoli M., Iacobellis G., et al. Tejido adiposo epicárdico y su asociación con niveles plasmáticos de adrenomedulina en pacientes con síndrome metabólico. Endocrinol Nutr 2011, 58:401-408.
45. Iacobellis G., di Gioia C.R., di Vito M., Petramala L., Cotesta D., de Santis V., et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res 2009, 41:855-860.
46. Silaghi A., Achard V., Paulmyer-Lacroix O., Scridon T., Tassistro V., Duncea I. Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. Am J Physiol Endocrinol Metab 2007, 293:E1443-E1450.
47. Greenstein A.S., Khavandi K., Whiters S.B., Sonoyama K., Clancy O., Jeziorska M., et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009, 119:1661-1670.
48. Pang C., Gao Z., Yin J., Zhang J., Jia W., Ye J. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am J Physiol Endocrinol Metab 2008, 295:E313-E322.
49. Cheng K.H., Chu C.S., Lee K.T., Lin T.H., Hsieh C.C., Chiu C.C., et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with CAD. Int J Obes (Lond) 2008, 32:268-274.
50. Karastergiou K., Evans I., Ogston N., Miheisi N., Nair D., Kaski J.C., et al. Epicardial adipokines in obesity and CAD induce atherogenic changes in monocytes and endothelial cells. Arterioscler Thromb Vasc Biol 2010, 30:1340-1346.
51. Payne G.A., Bohlen H.G., Dincer U.D., Borbouse L., Tune J.D. Periadventitial adipose tissue impairs coronary endothelial function via PKC-β dependent phosphorylation of nitric oxide synthase. Am J Physiol Heart Circ Physiol 2009, 297:H460-H465.
52. Payne G.A., Borbouse L., Kumar S., Neeb Z., Alloosh M., Sturek M., et al. Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-β pathway. Arterioscler Thromb Vasc Biol 2010, 30:1711-1717.
53. Gupta G.K., Agrawal T., Delcore M.G., Mohiuddin S.M., Agrawal D.K. Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine. Exp Mol Pathol 2012, 93:82-90.
54. Iacobellis G. Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:345-353.
55. Iacobellis G., Assael F., Ribaudo M.C., Zappaterreno A., Alesi G., di Mario U., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003, 11:304-310.
56. Lima-Martínez M.M., Balladares N., Torres C., Guerra E., Contreras M.A. Medición ecocardiográfica de la grasa epicárdica. Imagen Diagn 2011, 2:23-26.
57. Iacobellis G., Willens H.J. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009, 22:1311-1319.
58. Iacobellis G., Willens H.J., Barbaro G., Sharma A.M. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008, 16:887-892.
59. Porter S.A., Massaro J.M., Hoffmann U., Vasan R.S., O'Donnel C.J., Fox C.S. Abdominal subcutaneous adipose tissue: a protective fat depot?. Diabetes Care 2009, 32:1068-1075.
60. Verhagen S.N., Visseren F.L. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis 2011, 214:3-10.
61. Gorter P.M., van Lindert A.S., de Vos A.M., Meijs M.F.L., van der Graaf Y., Doevendans P.A., et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008, 197:896-903.
62. Iacobellis G., Ribaudo M.C., Assael F., Vecci E., Tiberti C., Zappaterreno A., et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88:5163-5168.
63. Iozzo P., Lautamaki R., Borra R., Lehto H.R., Bucci M., Viljanen A., et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009, 94:4472-4482.
64. Lima Martínez M.M. Síndrome metabólico y riesgo cardiovascular: un enfoque fisiopatológico 2011, Editorial Académica Española;, Saarbrüken. 1.a ed.
65. Lima M.M., Rosa F., Marin A., Balladares N., Guerra E., Nuccio A.G. Adipocitoquinas nóveles y su interrelación en el fenómeno de resistencia a la insulina. Infor Med 2009, 11:583-588.
66. Ueno K., Anzai T., Jinzaki M., Yamada M., Jo Y., Maekawa Y., et al. Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J 2009, 73:1927-1933.
67. Iacobellis G., Barbaro G., Gerstein H.C. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol 2008, 128:424-426.
68. Iacobellis G., Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005, 90:6300-6302.
69. Mazur A., Ostanski M., Telega G., Malecka-Tendera E. Is epicardial fat tissue a marker of metabolic syndrome in obese children?. Atherosclerosis 2010, 211:596-600.
70. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004, 94:1084-1087.
71. Mookadam F., Goel R., Alharthi M.S., Jiamsripong P., Cha S. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views 2010, 11:103-108.
72. Iozzo P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011, 34:S371-S379.
73. Mureddu G.F., Greco R., Rosato G.F. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity. Int J Obes Relat Metab Disord 1998, 22:363-368.
74. Lima M.M., Nuccio J.C., Villalobos M., Torres C., Balladares N. Sistema renina angiotensina y riesgo cardiometabólico. Rev Venez Endocrinol Metab 2010, 8:3-10.
75. Iacobellis G. Relation of epicardial fat thickness to right ventricular cavity size in obese subjects. Am J Cardiol 2009, 104:1601-1602.
76. Iacobellis G., Leonetti F., Singh N., Sharma A. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol 2007, 115:272-273.
77. Shin S.Y., Yong H.S., Lim H.E., Na J.O., Choi C.U., Choi J.I., et al. Total, interatrial epicardial adipose tissue are independently associated with left atrial remodeling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011, 22:647-655.
78. Jeong J.W., Jeong M.H., Yun K.H., Oh S.K., Park E.M., Kim Y.K. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007, 71:536-539.
79. Yun K.H., Rhee S.J., Yoo N.J., Oh S.K., Kim N.H., Jeong J.W., et al. Relationship between the echochardiographic epicardial adipose tissue thickness and serum adiponectin in patients with angina. J Cardiovasc Ultrasound 2009, 17:121-126.
80. Wang C.P., Hsu H.L., Hung W.C., Yu T.H., Chen Y.H., Chiu C.A., et al. Increased epicardial adipose tissue volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) 2009, 70:876-882.
81. Cheng V.Y., Dey D., Tamarappoo B., Nakazato R., Gransar H., Miranda-Peats R., et al. Pericardial fat burden on ECG-gated non-contrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. JACC Cardiovasc Imaging 2010, 3:352-360.
82. Ding J., Hsu F.C., Harris T.B., Liu Y., Kritchevsky S.B., Szklo M., et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009, 90:499-504.
83. Iacobellis G., Lonn E., Lamy A., Singh N., Sharma A.M. Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol 2011, 146:452-454.
84. Natale F., Tedesco M.A., Mocerino R., de Simone V., di Marco G.M., Aronne L., et al. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 2009, 10:549-555.
85. Rego J.O., Iacobellis G., Sarmientos J.C., Mustelier J.V., Aquiles E.W., Rodríguez V.M., et al. Epicardial fat thickness correlates with ApoB/ApoA1 ratio, coronary calcium and carotid intima media thickness in asymptomatic subjects. Int J Cardiol 2011, 151:234-236.
86. Konishi M., Sugiyama S., Sugamura K., Nozaki T., Ohba K., Matsubara J., et al. Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 2010, 209:573-578.
87. Alexopoulos N., McLean D.S., Janik M., Arepalli C.D., Stillman A.E., Raggi P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010, 210:150-154.
88. Ishikawa Y., Akasaka Y., Ito K., Akishima Y., Kimura M., Kiguchi H., et al. Significance of anatomical properties of myocardial bridge on atherosclerosis evolution in the left anterior descending coronary artery. Atherosclerosis 2006, 186:380-389.
89. Ishikawa Y., Akasaka Y., Suzuki K., Fujiwara M., Ogawa T., Yamazaki K., et al. Anatomic properties of myocardial bridge predisposing to myocardial infarction. Circulation 2009, 120:376-383.
90. Xu Y., Cheng X., Hong K., Huang C., Wan L. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis 2012, 23:227-233.
91. Sharma A.M., Iacobellis G. Treatment of obesity: a challenging task. Contrib Nephrol 2006, 151:212-220.
92. Kim M.K., Tanaka K., Kim M.J., Matuso T., Endo T., Tomita T., et al. Comparison of epicardial, abdominal and regional fat compartments in response to weight loss. Nutr Metab Cardiovasc Dis 2009, 19:760-766.
93. Iacobellis G., Singh N., Wharton S., Sharma A.M. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) 2008, 16:1693-1697.
94. Kim M.K., Tomita T., Kim M.J., Sasai H., Maeda S., Tanaka K. Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol 2009, 106:5-11.
95. Willens H.J., Byers P., Chirinos J.A., Labrador E., Hare J.M., de Marchena E. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol 2007, 99:1242-1245.
96. Park J.H., Park Y.S., Kim Y.J., Lee I.S., Kim J.H., Lee J.H., et al. Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibe. J Cardiovasc Ultrasound 2010, 18:121-126.
97. Sacks H.S., Fain J.N., Cheema P., Bahouth S.W., Garrett E., Wolf R.Y., et al. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care 2011, 34:730-733.
98. Lanes R., Soros A., Flores K., Gunczler P., Carrillo E., Bandel J. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth-hormone deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 2005, 90:3978-3982.
99. Ferrante E, Malavazos AE, Giavoli C, Ermetici F, Coman C, Bergamaschi S, et al. Epicardial fat thickness significantly decreases after short-term growth hormone replacement therapy in adults with GH deficiency. Nutr Metab Cardiovasc Dis. 2012. en press.
100. Iacobellis G., Sharma A.M., Pellicelli A.M., Grisorio B., Barbarini G., Barbaro G. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome. Curr HIV Res 2007, 5:275-279.